---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-004371"
form_type: "8-K"
ticker: "CPMD"
cik: "0001081938"
company_name: "CANNAPHARMARX, INC."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:35:10.620087+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CannaPharmaRX appoints Dean Medwid as CEO; Dominic Colvin steps down

## Summary
- Dominic Colvin stepped down as CEO effective June 1, 2023; no disagreement over operations.
- Dean Medwid appointed CEO effective June 1, 2023; base salary of CDN $17,325/month plus bonus.
- Medwid has 30+ years experience, previously President of New Leaf Ventures, a cannabis company.
- Colvin will remain with the company providing 'leadership and vision.'
- No family relationships or material interests between Medwid and other officers/directors.

## SEC filing metadata
- accession: 0001683168-23-004371
- form_type: 8-K
- ticker: CPMD
- cik: 0001081938
- company_name: CANNAPHARMARX, INC.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/cannapharmarx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-004371
- JSON: https://secwatch.observer/filing/0001683168-23-004371.json
- Plain text: https://secwatch.observer/filing/0001683168-23-004371.txt

## Key facts
- Executive change
  Dean Medwid was appointed as Chief Executive Officer at CANNAPHARMARX, INC..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On June 1, 2023, the Company’s Board of Directors appointed Dean Medwid as Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm
- Executive change
  Dominic Colvin departed as Chief Executive Officer at CANNAPHARMARX, INC..
  - Action: stepped down
  - Role: Chief Executive Officer
  source text: Dominic Colvin stepped down as the Chief Executive Officer (“CEO”) of CannPharmaRX, Inc. (the “Company”) effective June 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1081938/000168316823004371/0001683168-23-004371-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.